The Pirbright Institute receives strategic funding from BBSRC

Recruitment for vacancies within The Pirbright Institute is managed on our behalf of the Institute by the RCUK Shared Services Ltd. To view or apply for this vacancy please visit the RCUK careers website, where an application form and further details can be found: http://www.topcareer.jobs/ www.topcareer.jobs/.

The vacancies listed below are still being recruited directly by The Pirbright Institute. For further information or application details on any of these particular vacancies please contact the institute directly via pirbright.hr@pirbright.ac.uk.

Jobs


: Select a site location.

Post RefJob TitleDetailsPDF FileClosing Date
15P-16Director of Risk and AssuranceABOUT US The Pirbright Institute, an institute sponsored by the Biotechnology and Biological Sciences Research Council (BBSRC), is a world-leading centre of excellence applying bioscience to enhance the UK capability to contain, control, and eliminate viral diseases of animals and viruses that spread from animals to humans. It supports the competitiveness of UK livestock and poultry producers, and improves the health and quality of life of both animals and people and our food security. The Institute employs 400 staff and has recently received £300 million of capital investment. THE ROLE Due to rapid expansion and growth, the Institute is seeking to appoint a Director of Risk & Assurance, an absolutely critical role in a new management team. The position will cover all aspects of the risk management and assurance function from an operational risk management perspective. This encompasses overall risk management, critically bio-risk management, together with the management of health & safety and environmental risks, which are all highly regulated areas of the Institute’s business. Quality assurance and business continuity are two other key responsibilities of the role. PDF10-04-2015
15P-009Group Leader or Fellow in Large DNA VirusesAfrican swine fever virus (ASFV) and Capripoxviruses have severe socio-economic impacts in many countries. ASFV in particular is of increasing global importance. The Pirbright Institute has a high profile, long-established multi-disciplinary research record in both of these areas, and is seeking to recruit new Group Leaders to complement and bolster existing activities. The post holders will establish research groups working on these large DNA viruses, relevant to animal health. The research programmes would likely focus on addressing areas such as: • Improving the understanding of virus / host interactions • The host response to virus • Mechanisms for evading host response • The development of improved tools for control • Epidemiology • Surveillance and diagnosis The proposed research programme would complement the Institute’s on-going research and fit within the strategic objectives of the Institute. The post holders will be expected to apply for and obtain external funding to develop their programmes of work. We are seeking applications from candidates who are either established Group Leaders with relevant track record, or outstanding early-career researchers with an interest in developing their own independent group. PDF05-04-2015
15P-11Administration Support for KE&C (Maternity Cover)An exciting opportunity for a highly motivated and resourceful individual to join the KE&C business unit and support one of the Institute’s core mission of maximising impact from our research. The KE&C team manages the institutes varied technology portfolio and supports the world-leading scientists in the delivery of their knowledge exchange and impact activities. This is a varied role and the successful candidate will provide the institute and team with the necessary support and continuity for existing activities. You will operate across the institute and in collaboration with colleagues in other departments. The successful candidate will join a team of 2 technology transfer professionals. PDF29-03-2015
15P-002Communications OfficerThe Communications department is responsible for the design, management and delivery of a strategic programme of Corporate Public Relations and Public Engagement activities. The team uses a variety of channels to reach a wide range of stakeholders with a view to ensuring an excellent reputation and profile for the Institute; identifying potential issues, threats and opportunities in a timely manner; participating in two-way engagement with the public on issues of importance to society that impact on the Institute’s science strategy and delivery; communicating scientific results and processes to lay audiences; and inspiring the next generation of scientists. These activities are considered best practice for science and are a requirement of strategic funding granted by BBSRC.PDF22-03-2015
15P-13Research Technician, Arthropod Genetics Group (part time 18.5 hours)This position is funded through an EU Horizon 2020 grant “Novel biocontrol agents for insect pests from neuroendocrinology”. Neuropeptides are potent regulators of many aspects of insect physiology and manipulating them potentially allows new methods for controlling pest insects. The grant is to a consortium of 14 academic, government and commercial institutions, primarily European, with expertise to address this topic from several directions. The Pirbright component, and hence this holder of this position, will focus on translational synthetic biology – in vivo applications and analysis through the expression of selected neuropeptides in transgenic insects. The initial model organism will be the diamondback moth, Plutella xylostella, a small, easily reared, short-generation-time insect of considerable economic importance. We aim to extend the current state of the art by engineering conditional non-cell-autonomous phenotypes based on expression of selected neuropeptides. At first we will aim for conditional lethality, for potential use in ‘sterile-male’ genetic control systems (see Alphey, Ann Rev Ent 2014 59:205-224); later we will engineer other behavioural and physiological phenotypes, based on emerging data from other consortium members regarding specific neuropeptides. Though the primary purpose is applied, the development of conditional-expression systems for selected neuropeptides in relevant pest insects will also provide a powerful tool for improving our understanding of these key signalling molecules. PDF22-03-2015
15P-14Senior Postdoctoral Research Scientist, Arthropod Genetics GroupThis position is funded through an EU Horizon 2020 grant “Novel biocontrol agents for insect pests from neuroendocrinology”. Neuropeptides are potent regulators of many aspects of insect physiology and manipulating them potentially allows new methods for controlling pest insects. The grant is to a consortium of 14 academic, government and commercial institutions, primarily European, with expertise to address this topic from several directions. The Pirbright component, and hence this holder of this position, will focus on translational synthetic biology – in vivo applications and analysis through the expression of selected neuropeptides in transgenic insects. The initial model organism will be the diamondback moth, Plutella xylostella, a small, easily reared, short-generation-time insect of considerable economic importance. We aim to extend the current state of the art by engineering conditional non-cell-autonomous phenotypes based on expression of selected neuropeptides. At first we will aim for conditional lethality, for potential use in ‘sterile-male’ genetic control systems (see Alphey, Ann Rev Ent 2014 59:205-224); later we will engineer other behavioural and physiological phenotypes, based on emerging data from other consortium members regarding specific neuropeptides. Though the primary purpose is applied, the development of conditional-expression systems for selected neuropeptides in relevant pest insects will also provide a powerful tool for improving our understanding of these key signalling molecules. PDF22-03-2015
15P-12Research Scientist, Arthropod Genetics Group This position is funded through an EU Horizon 2020 grant “Novel biocontrol agents for insect pests from neuroendocrinology”. Neuropeptides are potent regulators of many aspects of insect physiology and manipulating them potentially allows new methods for controlling pest insects. The grant is to a consortium of 14 academic, government and commercial institutions, primarily European, with expertise to address this topic from several directions. The Pirbright component, and hence this holder of this position, will focus on translational synthetic biology – in vivo applications and analysis through the expression of selected neuropeptides in transgenic insects. The initial model organism will be the diamondback moth, Plutella xylostella, a small, easily reared, short-generation-time insect of considerable economic importance. We aim to extend the current state of the art by engineering conditional non-cell-autonomous phenotypes based on expression of selected neuropeptides. At first we will aim for conditional lethality, for potential use in ‘sterile-male’ genetic control systems (see Alphey, Ann Rev Ent 2014 59:205-224); later we will engineer other behavioural and physiological phenotypes, based on emerging data from other consortium members regarding specific neuropeptides. Though the primary purpose is applied, the development of conditional-expression systems for selected neuropeptides in relevant pest insects will also provide a powerful tool for improving our understanding of these key signalling molecules. PDF22-03-2015
14P-98Research Assistant African Swine Fever Virus GroupThe post-holder will be employed on a Super Follow on Fund Research Grant from BBSRC: “Further development of an African swine fever virus live attenuated vaccine”. African swine fever virus causes an acute haemorrhagic fever with high mortality in domestic pigs and has a high socio-economic impact in affected countries. There is currently no vaccine available and this limits options for disease control. Previous work at The Pirbright Institute has identified an attenuated ASFV strain which induces protective immunity in pigs against lethal challenge with virulent virus. The purpose of this project will be to carry out further studies on this attenuated ASFV strain to evaluate its potential for commercial development. These additional studies will include evaluating the induction of protective immune responses and clinical signs following administration to pigs by different routes and doses. In addition persistence and shedding of the attenuated virus from pigs will be studied and ability to induce cross-protection against different isolates. In parallel the growth of the virus in cells will be optimized and stability over passage determined. PDF18-03-2015

Further particulars on the Fellowships and how to apply can be found here.

Fellowships


No Fellowships are available.